NDC 49288-0628

Jerusalem Oak

Jerusalem Oak

Jerusalem Oak is a Intradermal; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Antigen Laboratories, Inc.. The primary component is Chenopodium Botrys Pollen.

Product ID49288-0628_8b59a012-60d1-4fa4-9ee7-fe89524760a2
NDC49288-0628
Product TypeHuman Prescription Drug
Proprietary NameJerusalem Oak
Generic NameJerusalem Oak
Dosage FormInjection, Solution
Route of AdministrationINTRADERMAL; SUBCUTANEOUS
Marketing Start Date1974-03-23
Marketing CategoryBLA / BLA
Application NumberBLA102223
Labeler NameAntigen Laboratories, Inc.
Substance NameCHENOPODIUM BOTRYS POLLEN
Active Ingredient Strength0 g/mL
Pharm ClassesNon-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS]
NDC Exclude FlagE
Listing Certified Through2017-12-31

Packaging

NDC 49288-0628-1

2 mL in 1 VIAL, MULTI-DOSE (49288-0628-1)
Marketing Start Date1974-03-23
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 49288-0628-1 [49288062801]

Jerusalem Oak INJECTION, SOLUTION
Marketing CategoryBLA
Application NumberBLA102223
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1974-03-23
Inactivation Date2019-10-21

NDC 49288-0628-4 [49288062804]

Jerusalem Oak INJECTION, SOLUTION
Marketing CategoryBLA
Application NumberBLA102223
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1974-03-23
Inactivation Date2019-10-21

NDC 49288-0628-3 [49288062803]

Jerusalem Oak INJECTION, SOLUTION
Marketing CategoryBLA
Application NumberBLA102223
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1974-03-23
Inactivation Date2019-10-21

NDC 49288-0628-5 [49288062805]

Jerusalem Oak INJECTION, SOLUTION
Marketing CategoryBLA
Application NumberBLA102223
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1974-03-23
Inactivation Date2019-10-21

NDC 49288-0628-2 [49288062802]

Jerusalem Oak INJECTION, SOLUTION
Marketing CategoryBLA
Application NumberBLA102223
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1974-03-23
Inactivation Date2019-10-21

Drug Details

Active Ingredients

IngredientStrength
CHENOPODIUM BOTRYS POLLEN.05 g/mL

OpenFDA Data

SPL SET ID:b8e9933d-eeb3-4379-aaa4-5dfb1179683f
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1014742
  • 851933
  • 852049
  • 1014746
  • 851937
  • 852512
  • 1014339
  • 852554
  • 852596
  • 1014705
  • 852535
  • 995746
  • 852082
  • 852542
  • 852240
  • 897378
  • 897506
  • 897319
  • 899534
  • 851929
  • 995611
  • 896120
  • 898010
  • 852010
  • 898329
  • 851988
  • 852014
  • 851984
  • 1232608
  • 1014769
  • 896224
  • 852032
  • 1115931
  • 852216
  • 896249
  • 852212
  • 852745
  • 851941
  • 897953
  • 852077
  • 852099
  • 897307
  • 852090
  • 1098396
  • 1006353
  • 1117086
  • 885753
  • 897991
  • 895729
  • 1115927
  • 895922
  • 1006498
  • 852001
  • 1014450
  • 852161
  • 897394
  • 851972
  • 852023
  • 896259
  • 901035
  • 995604
  • Pharmacological Class

    • Non-Standardized Pollen Allergenic Extract [EPC]
    • Increased Histamine Release [PE]
    • Cell-mediated Immunity [PE]
    • Increased IgG Production [PE]
    • Pollen [CS]
    • Allergens [CS]

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.